ELV — Elevance Health Inc.

Elevance Health (ELV) Q1 2026 Earnings Call Summary

1. Key Financial Results and Metrics

• Adjusted Diluted EPS: $12.58, exceeding expectations.
• Operating Revenue: $49.5 billion, up 1.5% year-over-year.
• Membership: 45.4 million members, an increase of nearly 200,000 from year-end.
• Benefit Expense Ratio: 86.8%.
• Operating Expense Ratio: 10.5%, improved by 20 basis points year-over-year.
• Operating Cash Flow: $4.3 billion; full-year expectation of at least $5.5 billion.
• Share Repurchases: 3.7 million shares for $1.1 billion at an average price of over $300 per share.

2. Strategic Updates and Business Highlights

• Strategic Focus: Elevance aims to lower healthcare costs and simplify navigation for members and providers.
• Leadership Realignment: Strengthened coordination between health benefits and Carelon to enhance execution.
• AI Integration: Embedding AI across operations to improve member engagement, cost management, and administrative efficiency.
• Carelon Transformation: Advancing integrated whole health approaches, resulting in a 20% reduction in hospital readmissions and over 10% savings on post-acute care.
• Medicaid Initiatives: Early evidence of cost reduction through targeted interventions in behavioral health and specialty pharmacy.

3. Forward Guidance and Outlook

• Revised Full-Year 2026 EPS Guidance: Raised to at least $26.75, reflecting confidence in business trajectory.
• 2027 Growth Expectation: Projecting at least 12% adjusted EPS growth off a revised baseline of $25.75.
• Medicare Advantage: On track for an operating margin of at least 2% in 2026.
• Commercial Business: Strong employer interest and a robust pipeline for 2027.

4. Bad News, Challenges, or Points of Concern

• Medicaid Margin Pressure: Expected operating margin of approximately -1.75% for the year, with ongoing eligibility reverifications and disenrollment impacting membership.
• CMS Risk Adjustment Data: A $935 million accrual recorded due to historical risk adjustment data issues, with ongoing constructive engagement with CMS.
• Membership Mix Concerns: Potential declines in lower-utilizing members could pressure the risk pool, particularly in Medicaid.
• Cost Management: Elevated underlying cost trends, particularly in Medicaid, remain a concern.

5. Notable Q&A Insights

• Commercial Market Dynamics: Employers are increasingly focused on affordability and simplifying the healthcare experience, driving strong demand for integrated medical and pharmacy solutions.
• AI and Automation: Progress in AI deployment is expected to yield efficiency gains, with specific examples of improved member navigation and reduced administrative burdens.
• Medicaid Membership Trends: The company remains comfortable with its guidance despite potential membership pressures from state reverification processes.
• Carelon's Role: Carelon's risk-based programs are expanding, with positive early indicators of improved care coordination and cost management.

Overall, Elevance Health reported a strong start to 2026, with positive financial metrics and strategic initiatives aimed at enhancing operational efficiency and member engagement, despite facing challenges in Medicaid margins and regulatory scrutiny.